The FDA just approved the first gene editing therapy for sickle cell anemia, but it'll cost $2.2 million per person

The FDA approved the first gene therapy for sickle cell anemia. Meletios Verras/ iStock The FDA approved the first gene therapies for sickle cell anemia. The…

Related Keywords

Meletios Verras , , News , Ggregator , Reaking News , Uration , Media ,